Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Primary Objectives:
1. To determine the efficacy of combining Interferon Alpha (IFN) with etoposide for the
treatment of relapsed osteosarcoma.
2. To determine if IFN alters the plasma pharmacokinetics of etoposide.
3. To determine the toxicities of IFN and etoposide when administered together.
4. To determine IFN blood levels following combination therapy.